184 related articles for article (PubMed ID: 32462907)
1. Radiobiologically derived biphasic fractionation schemes to overcome the effects of tumour hypoxia.
Joseph N; Kirkby NF; Hoskin PJ; West CML; Choudhury A; Dale RG
Br J Radiol; 2020 Aug; 93(1112):20190250. PubMed ID: 32462907
[TBL] [Abstract][Full Text] [Related]
2. Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlates with reoxygenation.
Petersen C; Zips D; Krause M; Schöne K; Eicheler W; Hoinkis C; Thames HD; Baumann M
Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):483-93. PubMed ID: 11567825
[TBL] [Abstract][Full Text] [Related]
3. Treatment fractionation for stereotactic radiotherapy of lung tumours: a modelling study of the influence of chronic and acute hypoxia on tumour control probability.
Lindblom E; Antonovic L; Dasu A; Lax I; Wersäll P; Toma-Dasu I
Radiat Oncol; 2014 Jun; 9():149. PubMed ID: 24974778
[TBL] [Abstract][Full Text] [Related]
4. Impact of SBRT fractionation in hypoxia dose painting - Accounting for heterogeneous and dynamic tumor oxygenation.
Kjellsson Lindblom E; Ureba A; Dasu A; Wersäll P; Even AJG; van Elmpt W; Lambin P; Toma-Dasu I
Med Phys; 2019 May; 46(5):2512-2521. PubMed ID: 30924937
[TBL] [Abstract][Full Text] [Related]
5. Modelling the interplay between hypoxia and proliferation in radiotherapy tumour response.
Jeong J; Shoghi KI; Deasy JO
Phys Med Biol; 2013 Jul; 58(14):4897-919. PubMed ID: 23787766
[TBL] [Abstract][Full Text] [Related]
6. Treating Glioblastoma Multiforme (GBM) with super hyperfractionated radiation therapy: Implication of temporal dose fractionation optimization including cancer stem cell dynamics.
Yu VY; Nguyen D; O'Connor D; Ruan D; Kaprealian T; Chin R; Sheng K
PLoS One; 2021; 16(2):e0245676. PubMed ID: 33524046
[TBL] [Abstract][Full Text] [Related]
7. Radiobiological prediction of normal tissue toxicities and tumour response in the radiotherapy of advanced non-small-cell lung cancer.
Singer JM; Price P; Dale RG
Br J Cancer; 1998 Dec; 78(12):1629-33. PubMed ID: 9862575
[TBL] [Abstract][Full Text] [Related]
8. The optimal fraction size in high-dose-rate brachytherapy: dependency on tissue repair kinetics and low-dose rate.
Sminia P; Schneider CJ; Fowler JF
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):844-9. PubMed ID: 11849810
[TBL] [Abstract][Full Text] [Related]
9. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.
; Bentzen SM; Agrawal RK; Aird EG; Barrett JM; Barrett-Lee PJ; Bliss JM; Brown J; Dewar JA; Dobbs HJ; Haviland JS; Hoskin PJ; Hopwood P; Lawton PA; Magee BJ; Mills J; Morgan DA; Owen JR; Simmons S; Sumo G; Sydenham MA; Venables K; Yarnold JR
Lancet Oncol; 2008 Apr; 9(4):331-41. PubMed ID: 18356109
[TBL] [Abstract][Full Text] [Related]
10. Monte Carlo radiotherapy simulations of accelerated repopulation and reoxygenation for hypoxic head and neck cancer.
Harriss-Phillips WM; Bezak E; Yeoh EK
Br J Radiol; 2011 Oct; 84(1006):903-18. PubMed ID: 21933980
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of incomplete repair parameters for rat spinal cord: the feasibility of large doses per fraction in PDR and HDR brachytherapy.
Pop LA; Millar WT; Visser AG; van der Kogel AJ
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):215-26. PubMed ID: 11516872
[TBL] [Abstract][Full Text] [Related]
12. Altered fractionation in the management of head and neck cancer.
Ang KK
Int J Radiat Biol; 1998 Apr; 73(4):395-9. PubMed ID: 9587077
[TBL] [Abstract][Full Text] [Related]
13. Optimal fractionation in radiotherapy for non-small cell lung cancer--a modelling approach.
Lindblom E; Dasu A; Toma-Dasu I
Acta Oncol; 2015; 54(9):1592-8. PubMed ID: 26217986
[TBL] [Abstract][Full Text] [Related]
14. Time factor for acute tissue reactions following fractionated irradiation: a balance between repopulation and enhanced radiosensitivity.
Hopewell JW; Nyman J; Turesson I
Int J Radiat Biol; 2003 Jul; 79(7):513-24. PubMed ID: 14530160
[TBL] [Abstract][Full Text] [Related]
15. Effect of reoxygenation on hypofractionated radiotherapy of prostate cancer.
Kuperman VY; Lubich LM
Med Phys; 2020 Oct; 47(10):5383-5391. PubMed ID: 32583529
[TBL] [Abstract][Full Text] [Related]
16. Programming of radiotherapy in the treatment of non-small-cell lung cancer--a way to advance care.
Saunders MI
Lancet Oncol; 2001 Jul; 2(7):401-8. PubMed ID: 11905734
[TBL] [Abstract][Full Text] [Related]
17. A radiobiological model of reoxygenation and fractionation effects.
Guerrero M; Carlson DJ
Med Phys; 2017 May; 44(5):2002-2010. PubMed ID: 28273349
[TBL] [Abstract][Full Text] [Related]
18. A treatment planning study evaluating a 'simultaneous integrated boost' technique for accelerated radiotherapy of stage III non-small cell lung cancer.
Dirkx ML; van Sörnsen De Koste JR; Senan S
Lung Cancer; 2004 Jul; 45(1):57-65. PubMed ID: 15196735
[TBL] [Abstract][Full Text] [Related]
19. Altered fractionation outcomes for hypoxic head and neck cancer using the HYP-RT Monte Carlo model.
Harriss-Phillips WM; Bezak E; Yeoh EK
Br J Radiol; 2013 Apr; 86(1024):20120443. PubMed ID: 23392195
[TBL] [Abstract][Full Text] [Related]
20. Morphological correlates of fractionated radiation of the mouse lung: early and late effects.
Penney DP; Siemann DW; Rubin P; Maltby K
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):789-804. PubMed ID: 8040026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
